A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases.

Fiveash, John B; Arafat, Waleed O; Naoum, George E; Guthrie, Barton L; Sawrie, Stephen M; Spencer, Sharon A; Meredith, Ruby F; Markert, James M; Conry, Robert M; Nabors, Burt L

Fiveash, John B; Arafat, Waleed O; Naoum, George E; Guthrie, Barton L; Sawrie, Stephen M; Spencer, Sharon A; Meredith, Ruby F; Markert, James M; Conry, Robert M; Nabors, Burt L.

Afiliación

Fiveash JB; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
Arafat WO; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
Naoum GE; Clinical Oncology Department, University of Alexandria, Alexandria, Egypt.
Guthrie BL; Alexandria Comprehensive Cancer Center, Alexandria, Egypt.
Sawrie SM; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
Spencer SA; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
Meredith RF; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
Markert JM; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
Conry RM; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
Nabors BL; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.

Adv Radiat Oncol ; 1(2): 83-88, 2016.

Article en En | MEDLINE | ID: mdl-28740873

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Adv Radiat Oncol Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google